Radiation dose and fluoroscopy time of modern endovascular treatment techniques in patients with saccular unruptured intracranial aneurysms.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 03 11 2019
accepted: 24 02 2020
revised: 18 02 2020
pubmed: 21 3 2020
medline: 5 1 2021
entrez: 21 3 2020
Statut: ppublish

Résumé

Modern endovascular treatment of unruptured intracranial aneurysms (UIAs) demands for observance of diagnostic reference levels (DRLs). The national DRL (250 Gy cm A retrospective single-centre study of saccular UIAs treated between 2015 and 2019. Regarding dosimetric analysis, the parameters dose area product (DAP) and fluoroscopy time were investigated for the following variables: endovascular technique, aneurysm location, DSA protocol, aneurysm size, and patient age. Eighty-seven patients (59 females, mean age 54 years) were included. Total mean and median DAP (Gy cm This UIA study establishes novel local DRLs for modern endovascular techniques such as FD and WEB. A low-dose protocol yielded a significant reduction of radiation dose. • This paper establishes local diagnostic reference levels for modern endovascular treatment techniques of unruptured intracranial aneurysms, including flow diverter stenting and Woven EndoBridge device. • Dose area product was not significantly different between endovascular techniques and aneurysm locations, but associated with aneurysm size and patient age. • A low-dose protocol yielded a significant reduction of dose area product and is particularly useful when applying materials with a high radiopacity (e.g. platinum coils).

Identifiants

pubmed: 32193640
doi: 10.1007/s00330-020-06777-x
pii: 10.1007/s00330-020-06777-x
pmc: PMC8093177
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4504-4513

Commentaires et corrections

Type : ErratumIn

Références

Eur Radiol. 2007 Jun;17(6):1621-33
pubmed: 17072616
J Vasc Interv Radiol. 2003 Jun;14(6):711-27
pubmed: 12817038
Radiology. 2013 Jun;267(3):858-68
pubmed: 23418004
Eur Radiol. 2019 Feb;29(2):645-653
pubmed: 30019142
Phys Med. 2012 Jan;28(1):61-70
pubmed: 21074469
Neurointervention. 2016 Sep;11(2):78-85
pubmed: 27621943
Radiology. 2003 May;227(2):522-8
pubmed: 12637677
Eur Radiol. 2019 Jul;29(7):3506-3515
pubmed: 30903333
Lancet. 2005 Sep 3-9;366(9488):809-17
pubmed: 16139655
Lancet. 2015 Feb 21;385(9969):691-7
pubmed: 25465111
Radiology. 2013 Nov;269(2):553-60
pubmed: 23737536
Radiology. 2009 Dec;253(3):753-64
pubmed: 19789226
J Neurointerv Surg. 2018 Jun;10(6):553-559
pubmed: 28965106
Korean J Radiol. 2014 Nov-Dec;15(6):844-9
pubmed: 25469098
Ann ICRP. 2017 Oct;46(1):1-144
pubmed: 29065694
AJNR Am J Neuroradiol. 2013 Jun-Jul;34(6):1209-14
pubmed: 23292529
J Neurointerv Surg. 2010 Mar;2(1):6-10
pubmed: 21990551
J Neurointerv Surg. 2019 Mar;11(3):290-295
pubmed: 30082333
AJNR Am J Neuroradiol. 2015 Dec;36(12):2314-9
pubmed: 26228882
Eur Radiol. 2018 Sep;28(9):3669-3675
pubmed: 29651772
AJNR Am J Neuroradiol. 2015 Mar;36(3):542-6
pubmed: 25376806
Interv Neurol. 2017 Oct;6(3-4):105-116
pubmed: 29118787

Auteurs

Robert Forbrig (R)

Institute of Neuroradiology, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany. robert.forbrig@med.uni-muenchen.de.

Yigit Ozpeynirci (Y)

Institute of Neuroradiology, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Matthias Grasser (M)

Siemens Healthineers, Forchheim, Germany.

Franziska Dorn (F)

Institute of Neuroradiology, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Thomas Liebig (T)

Institute of Neuroradiology, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Christoph G Trumm (CG)

Institute of Neuroradiology, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH